INS and diabetes mellitus: Flavan-3-ols and their colonic metabolites can modulate the molecular mechanisms involved in the pathogenesis of diabetes, including the glucose absorption rate in the gut, glucose peripheral uptake, glucose secretion, the modulation of beta cell function, the modulation of insulin secretion, and the modulation of the incretin effect (Figure 1).